After being referred by their physician, Medicare patients wait an average of 34 days to see a neurologist, according to ...

Hartford HealthCare and Aidoc today announced the launch of a new partnership to innovate and integrate tailored clinical ...

EEG-based emotional analysis achieves near-perfect accuracy in Parkinson’s diagnosis, offering a non-invasive, objective ...

Widely recognized as the global benchmark for nursing excellence, the award highlights the hospital's commitment to ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Inemuri, the Japanese art of napping, allows individuals to take short naps in public or work settings without being seen as ...

The FDA will decide later this month whether to approve a novel drug for acute pain that could offer a nonaddictive ...

Primary endpoint of overall function (ALSFRS-R) and survival, and key secondary endpoints of muscle strength and respiratory function, were not met at 24 weeksOverall, DNL343 was found to be safe and ...

BR Exclusive - Operating across six EU countries, SOFMEDICA has consistently pushed boundaries in delivering cutting-edge ...

EQS-News: Newron Pharmaceuticals S.p.A. / Key word (s): Agreement Newron and Myung In Pharm announce license agreement for evenamide in South Korea 09.01.2025 / 07:00 CET/CEST The issuer is solely ...